Skip to content

The effect of adjuvant vitamin C after varicocele surgery for improvement in sperm formation in infertile men

The effect of adjuvant oral vitamin C therapy after varicocele surgery for improvement in sperm formation in infertile men

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201103042134N2
Enrollment
84
Registered
2011-12-27
Start date
2010-02-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Varicocele. Condition 2: Male infertility. Scrotal varices Male infertility

Interventions

Intervention 1: The control group receives two daily doses of starch-filled capsules as placebo, for 3 months after the surgery. Intervention 2: The control group receives two daily doses of capsules
Placebo
Treatment - Drugs
The control group receives two daily doses of starch-filled capsules as placebo, for 3 months after the surgery.
The control group receives two daily doses of capsules filled with 500 mg of vitamin C (Osveh pharmaceuticals- Ref No. 1228038410) for 3 months after the surgery.

Sponsors

Vice chancellor for research, Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Palpable varicocele (grade 2 or 3) in physical examination; Abnormality in count, motility, or morphology of sperm in two separate semen analyses based on WHO criteria; No azoospermia; No major underlying disease such as: diabetes or hormonal abnormalities based on history and physical examination; Not smoker or addicted to any recreational drugs; Not using any drugs or supplements on a regular basis; Age between 18-50 years; Weight between 50-100 kg; No active or chronic genitourinary infection based on history, physical examination, urine analysis, and semen analysis; No previous history of peptic ulcer disease or vitamin C intolerance Exclusion criteria: Patients' unwillingness to continue participation; Not attending follow up visits; Incorrect utilization of the capsules; Occurrence of side effects due to capsules; Late complications of surgery such as hydrocele, recurrence of varicocele, or testis atrophy; Commencement of smoking or addiction during the follow up

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sperm motility. Timepoint: Before and 3 months after the surgery. Method of measurement: Mean percent of motile sperm class A+B in two separate semen analyses.;Sperm count. Timepoint: Before and 3 months after the surgery. Method of measurement: Mean concentration of sperm in two separate semen analyses.;Sperm morphology. Timepoint: Before and 3 months after the surgery. Method of measurement: Mean percent of sperm with normal morphology based on WHO criteria in two separate semen analyses.

Secondary

MeasureTime frame
Side effects. Timepoint: During the 3-month period of follow up. Method of measurement: Bases on patients' report on monthly visits.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Ali Cyrus

Arak University of Medical Sciences

cyrus@arakmu.ac.ir+98 86 1222 1041

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026